United States· US:84204-0005_2bc46001-3695-4135-e063-6294a90a2a00
Black Girl Sunscreen
A medicinal product containing homosalate; octisalate; avobenzone; octocrylene, registered in United States by Black Girl Sunscreen, LLC.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- HOMOSALATE; OCTISALATE; AVOBENZONE; OCTOCRYLENE
- Manufacturer
- Black Girl Sunscreen, LLC
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc11842040005350 mL in 1 TUBE (84204-0005-3)
- ndc1184204-0005-3
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e45ec474-8b1e-4dac-85f5-5a49ea6540f8 GET /v1/drugs/e45ec474-8b1e-4dac-85f5-5a49ea6540f8?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "TOPICAL",
"source": "ndc",
"strength": "79; 39.5; 23.7; 39.5",
"substance": "HOMOSALATE; OCTISALATE; AVOBENZONE; OCTOCRYLENE",
"productndc": "84204-0005",
"dosage_form": "GEL",
"dea_schedule": null,
"strength_unit": "mg/mL; mg/mL; mg/mL; mg/mL",
"application_number": "M020",
"marketing_category": "OTC MONOGRAPH DRUG"
}See everything about homosalate; octisalate; avobenzone; octocrylene.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.